Detalhe da pesquisa
1.
Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands.
J Infect Dis
; 227(9): 1059-1067, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477364
2.
Tularemia Transmission to Humans, the Netherlands, 2011-2021.
Emerg Infect Dis
; 28(4): 883-885, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318921
3.
Prevalence and determinants of persistent symptoms after treatment for Lyme borreliosis: study protocol for an observational, prospective cohort study (LymeProspect).
BMC Infect Dis
; 19(1): 324, 2019 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987580
4.
HEVnet: a One Health, collaborative, interdisciplinary network and sequence data repository for enhanced hepatitis E virus molecular typing, characterisation and epidemiological investigations.
Euro Surveill
; 24(10)2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862334
5.
Risk factors for hepatitis E virus seropositivity in Dutch blood donors.
BMC Infect Dis
; 18(1): 173, 2018 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653521
6.
Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection.
Heliyon
; 10(7): e28941, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38617937
7.
Corrections to "Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study" [The Lancet Regional Health - Europe 6 (2021) 100142].
Lancet Reg Health Eur
; 27: 100622, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968322
8.
Determinants of persistent symptoms after treatment for Lyme borreliosis: a prospective observational cohort study.
EBioMedicine
; 98: 104825, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016860
9.
Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
BMJ Open
; 12(7): e062439, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777877
10.
Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study.
Lancet Reg Health Eur
; 6: 100142, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34557833
11.
[Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands]. / Vaccinatieprogramma's in Nederland.
Ned Tijdschr Geneeskd
; 1622018 09 20.
Artigo
em Holandês
| MEDLINE | ID: mdl-30306758